NCT05917886

Brief Summary

The goal of this study is to examine the effects of auditory beat stimulation on anxiety in patients diagnosed with bvFTD. Main aims are:

  • to ascertain whether anxiety in bvFTD patients can be modulated using auditory beat stimulation
  • to investigate patterns of anxiety and mind wandering in bvFTD patient population Patients were asked to complete a number of questionnaires relating to well-being and mind wandering, as well as to listen daily to audio files of beat stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 1, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 26, 2023

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

7 months

First QC Date

June 1, 2023

Last Update Submit

June 14, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Examine anxiety modulation effects of monaural beat stimulation using the State-Trait Anxiety Inventory (STAI-S and T)

    The STAI Inventory was used to assess the patients' state (STAI-S) and trait (STAI-T) anxiety. The two subscores differentiate between transient feelings of anxiety (state anxiety), i.e. those related to a particular context like an event, and anxiety levels that are more of a personal characteristic of an individual (trait anxiety: Spielberger et al., 1983). Patients responded to 20 statements contained in each subscore, using a 4-point Likert scale (not at all: 1; a little: 2; quite: 3; very: 4). The STAI Inventory was completed at the beginning and end of each week.

    3 years

  • Examine depression modulation effects of monaural beat stimulation using the Beck Depression Inventory

    metric used to assess levels of depression; The BDI is a 21-item multiple-choice questionnaire (Beck et al., 1996). The BDI was used to assess symptoms of depression, and was administered at the beginning and end of each week, prior to the six-day daily course of auditory beat stimulation. The BDI is categorised into the following scoring ranges: 0-13 minimal; 14-19 mild; 20-28 moderate and 29-63 severe.

    3 years

  • Examine mind wandering modulation effects of monaural beat stimulation using the Mind Wandering Questionnaire

    The Mind Wandering Questionnaire is a short-form scale intended to measure the propensity to mind wander (Mrazek et al., 2013). The questionnaire consists of five items that evaluate trait levels of mind wandering. Trait mind wandering is scored across a 6-point Likert scale (1: almost never; 2: very infrequently; 3: somewhat infrequently; 4: somewhat frequently; 5: very frequently; 6: almost always). Patients completed this questionnaire, also at the beginning and end of each week.

    3 years

  • Examine daily momentary subjective levels of anxiety, mood and pain modulation effects of monaural beat stimulation using the Mind Wandering Questionnaire

    The Rogers' Happy/ Sad Face Scale is a visual-numeric scale that was intended to capture the momentary subjective levels of anxiety, mood and pain. Patients had to grade their feelings according to a corresponding face icon which represented a 'happy face' at the most positive end (value of 0) of the graded scale, all the way to a 'crying face' icon at the most negative end of the scale (value of 4). Patients completed this scale twice daily, once immediately prior to the auditory stimulation, and then immediately after the stimulation had concluded.

    3 years

Study Arms (2)

Monaural beat stimulation

ACTIVE COMPARATOR

20 min sound recording of 8Hz monaural beat

Other: Auditory beat stimulation: 8Hz monaural beat stimulation

Control

SHAM COMPARATOR

20 min sound recording of 220Hz pure sine wave

Other: Auditory beat stimulation: 8Hz monaural beat stimulation

Interventions

Auditory beat stimulation is a reversible, non-invasive application of sound to the ears.

ControlMonaural beat stimulation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • A. Early disinhibition B. Early apathy or passivity C. Early loss of compassion or empathy D. speech or motor stereotypies E. Hyperorality and altered eating habits F. Neuropsychological profile with executive function deficits with relatively unchanged memory and visuospatial performance G. Disruption of daily living skills H. Matching imaging (cMRI, cCT, PET).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Juergen Fell

Bonn, North Rhine-Westphalia, 53127, Germany

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants were unaware which auditory beat stimulation condition they received in which order.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Patients participated in both the control and active auditory beat conditions, each lasting 1 week. Conditions were randomised across participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Priniciple Investigator

Study Record Dates

First Submitted

June 1, 2023

First Posted

June 26, 2023

Study Start

January 1, 2021

Primary Completion

August 1, 2021

Study Completion

September 1, 2021

Last Updated

June 26, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

All data that cannot be identified will be made available upon request

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Available immediately and for the next 4 years
Access Criteria
Email and confirmation of usage.

Locations